about
Sickle cell disease--the American saga.Frequent red cell transfusions reduced vascular endothelial activation and thrombogenicity in children with sickle cell anemia and high stroke riskTranslating scientific advances to improved outcomes for children with sickle cell disease: a timely opportunity.Transition from pediatric to adult care for sickle cell disease: results of a survey of pediatric providers.Knowledge of family health program practitioners in Brazil about sickle cell disease: a descriptive, cross-sectional study.Evaluation and Treatment of Sickle Cell Pain in the Emergency Department: Paths to a Better FutureAttitudes toward clinical trials among patients with sickle cell disease.Effect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke.Burden of influenza-related hospitalizations among children with sickle cell diseaseConcentration of hospital care for acute sickle cell disease-related visitsIntranasal fentanyl versus intravenous morphine in the emergency department treatment of severe painful sickle cell crises in children: study protocol for a randomised controlled trial.Quality of assistance provided to children with sickle cell disease by primary healthcare services.Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions.Needs Assessment for Patients with Sickle Cell Disease in South Carolina, 2012Research to advance health and health care for individuals with sickle cell disease: a drop in the bucket of needed research.Newborn Screening Programs and Sickle Cell Disease: A Public Health Services and Systems ApproachPilot study of hemoglobinopathies in newborns of the Rafael Calvo maternity clinic of Cartagena, Colombia.Reproductive attitudes and behaviors in people with sickle cell disease or sickle cell trait: a qualitative interpretive meta-synthesis.Development of a New Adult Sickle Cell Disease Center Within an Academic Cancer Center: Impact on Hospital Utilization Patterns and Care Quality.Systematic and Meta-Analytic Review: Medication Adherence Among Pediatric Patients With Sickle Cell Disease.Intravenous Lidocaine as an Adjuvant for Pain Associated with Sickle Cell Disease.Challenges and resilience in the lives of adults with sickle cell disease.Sickle cell disease and implementation science: A partnership to accelerate advances.Barriers to conceiving sibling donors for sickle cell disease: perspectives from patients and parents.Perception of primary care doctors and nurses about care provided to sickle cell disease patients.Race matters: perceptions of race and racism in a sickle cell center.Sickle cell disease related internet activity is three times less frequent than cystic fibrosis related internet activity.Promoting equity: developing quality measures for sickle cell disease.Can I trust them to do everything? The role of distrust in ethics committee consultations for conflict over life-sustaining treatment among Afro-Caribbean patients.The Challenges and Opportunities Associated with Sickle Cell Disease Prevention, Education, and Management.Stigma of Sickle Cell Disease: A Systematic Review.Equitable health: let's stick together as we address global discrimination, prejudice and stigma
P2860
Q30371761-91912E78-8F44-4C31-8CAD-BA09FEAF1FE0Q33804615-4F0D9ACE-4ADF-4C56-AE08-E10E1471DBBCQ33871218-6865633F-9595-4775-AC3B-0D1862DCBA7DQ33905539-A1BC9EEC-FB10-4139-B56C-329C1547A6B8Q33997845-A2CBC676-DFDB-4163-AAA2-621CE8AF28F2Q34795456-6149D415-E941-496A-A527-76F730170656Q35287718-43F0721A-BDF4-4089-AEE2-C7A48A3EB7C9Q35754765-4B50AE85-F64A-4FA2-A697-5DDF0F02B76AQ35768280-D61661EA-FF98-48E4-BB2A-F4680E7129DAQ35848287-2D38D90E-F241-4B20-ADE4-A1F560268256Q36150411-B647D926-7F02-4664-930C-846D097E3356Q36153587-3F543CDC-426D-46A2-B66D-873A5FAFAD51Q36185410-048115A7-3A1B-4936-8795-A7F6792E69D3Q36472782-6E4363D9-A017-4615-804F-E749FE849C26Q36880417-219C0B9C-54E9-4E97-B859-317C7E573D56Q37027198-2E9E2CA1-C5AA-4F99-BCB4-50F7193A3444Q37727370-4A4438C5-7444-4197-B1CD-1CC7F58E45F3Q38053169-0F3043B9-7676-4C72-8E20-A6A6D3C7B939Q38382709-B22083E6-132C-4D22-AF17-D00B76298724Q38589127-4C4F954E-0995-4289-BFB7-DA56C63ABD57Q38665429-7524E930-A0DD-4F84-99BF-AE868957EBE7Q39270632-7B80DACB-07B8-4D63-8EA8-B100EF459941Q39337770-0F47DE63-1FA1-4ABE-8EAE-3D2EC46CFA9CQ39992806-7C566BF8-56A7-4280-A881-E032EDD41248Q40719737-266A5DA2-6AC2-4D73-9FA9-72B220B0AA90Q43433644-2C4F3122-56DE-4F74-A6B2-FB1DFB2109B1Q45855808-5A059BC5-9BEC-4728-926F-BCB739907148Q46924995-C8AB4441-DDC4-4211-96FB-A13E89D3AA92Q47749905-E0C6F2AB-06FF-4BAA-8184-D170C4C37ABDQ50283786-C88E1F56-D4B8-400F-A544-07A57796D70CQ53411601-73A960EF-2730-469F-91D7-E2B54B733F56Q58724459-5800A032-C6E4-4955-BF83-DDE4AAC25865
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Sickle cell disease: a question of equity and quality.
@ast
Sickle cell disease: a question of equity and quality.
@en
type
label
Sickle cell disease: a question of equity and quality.
@ast
Sickle cell disease: a question of equity and quality.
@en
prefLabel
Sickle cell disease: a question of equity and quality.
@ast
Sickle cell disease: a question of equity and quality.
@en
P356
P1433
P1476
Sickle cell disease: a question of equity and quality.
@en
P2093
Charles Homer
Suzette O Oyeku
P304
P356
10.1542/PEDS.2005-1611
P407
P577
2006-05-01T00:00:00Z